Location of Repository

Decreased Phosphatase Activity, Increased Ca2+ Sensitivity, and Myosin Light Chain Phosphorylation in Urinary Bladder Smooth Muscle of Newborn Mice

By Mari Ekman, Katarina Fagher, Mia Wede, Karolina Stakeberg and Anders Arner

Abstract

Developmental changes in the regulation of smooth muscle contraction were examined in urinary bladder smooth muscle from mice. Maximal active stress was lower in newborn tissue compared with adult, and it was correlated with a lower content of actin and myosin. Sensitivity to extracellular Ca2+ during high-K+ contraction, was higher in newborn compared with 3-wk-old and adult bladder strips. Concentrations at half maximal tension (EC50) were 0.57 ± 0.01, 1.14 ± 0.12, and 1.31 ± 0.08 mM. Force of the newborn tissue was inhibited by ∼45% by the nonmuscle myosin inhibitor Blebbistatin, whereas adult tissue was not affected. The calcium sensitivity in newborn tissue was not affected by Blebbistatin, suggesting that nonmuscle myosin is not a primary cause for increased calcium sensitivity. The relation between intracellular [Ca2+] and force was shifted toward lower [Ca2+] in the newborn bladders. This increased Ca2+ sensitivity was also found in permeabilized muscles (EC50: 6.10 ± 0.07, 5.77 ± 0.08, and 5.55 ± 0.02 pCa units, in newborn, 3-wk-old, and adult tissues). It was associated with an increased myosin light chain phosphorylation and a decreased rate of dephosphorylation. No difference was observed in the myosin light chain phosphorylation rate, whereas the rate of myosin light chain phosphatase–induced relaxation was about twofold slower in the newborn tissue. The decreased rate was associated with a lower expression of the phosphatase regulatory subunit MYPT-1 in newborn tissue. The results show that myosin light chain phosphatase activity can be developmentally regulated in mammalian urinary bladders. The resultant alterations in Ca2+ sensitivity may be of importance for the nervous and myogenic control of the newborn bladders

Topics: Article
Publisher: The Rockefeller University Press
OAI identifier: oai:pubmedcentral.nih.gov:2217499
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Preview

    Citations

    1. (2000). Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility.
    2. (1999). Ca2 -independent phosphorylation of myosin in rat caudal artery and chicken gizzard myofilaments.
    3. (2003). Ca2 sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase.
    4. (1998). Clostridium difficile toxin B inhibits carbachol-induced force and myosin light chain phosphorylation in guinea-pig smooth muscle: role of Rho proteins.
    5. (2001). Dedicated myosin light chain kinases with diverse cellular functions.
    6. (2000). Determinants of the contractile196 Regulation of Smooth Muscle Contraction During Development properties in the embryonic chicken gizzard and aorta.
    7. (1991). Developmental aspects of bladder contractile function: sensitivity to extracellular calcium.
    8. (1994). Developmental aspects of excitation contraction coupling of rabbit bladder smooth muscle.
    9. (2003). Developmental changes in spontaneous smooth muscle activity in the neonatal rat urinary bladder.
    10. (1985). Effects of calcium and substrate on force-velocity relation and energy turnover in skinned smooth muscle of the guinea-pig.
    11. (1997). Endothelin-1 alters the contractile phenotype of cultured embryonic smooth muscle cells.
    12. (1983). Force-velocity relation in chemically skinned rat portal vein.
    13. (1999). Inhibition of force and shortening in smooth muscle by vanadate. Pflugers Arch.
    14. (2004). Mechanism of blebbistatin inhibition of myosin II.
    15. (2004). Modulation of Ca2 sensitivity by cyclic nucleotides in smooth muscle from protein kinase G-deficient mice.
    16. (1998). Myosin heavy chain isoform expression in rat smooth muscle development.
    17. (2004). Myosin light chain kinase knockout.
    18. (2003). Nonmuscle myosin motor of smooth muscle.
    19. (2002). Pharmacologic perspective on the physiology of the lower urinary tract.
    20. (1994). Purification and characterization of the mammalian myosin light chain phosphatase holoenzyme. The differential effects of the holoenzyme and its subunits on smooth muscle.
    21. (1999). Reconstitution of protein kinase C-induced contractile Ca2 sensitization in triton X-100-demembranated rabbit arterial smooth muscle.
    22. (2001). Role of myosin phosphatase isoforms in cGMP-mediated smooth muscle relaxation.
    23. (2000). Smooth muscle myosin heavy chain isoforms and their role in muscle physiology.
    24. (2000). Smooth muscle myosin heavy chains are developmentally regulated in the rabbit bladder.
    25. (2002). Smooth muscle myosin phosphatase-associated kinase induces Ca2 sensitization via myosin phosphatase inhibition.
    26. (2000). Smooth-muscle contraction without smooth-muscle myosin.
    27. (2004). Urinary bladder contraction and relaxation: physiology and pathophysiology.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.